Current market catalysts

Braze Sees Q3 Adj EPS $0.13-$0.14 vs $0.16 Est; Sees Sales $229.000M-$230.000M vs $227.861M Est

Suniva Announces Completion Of $835M Debt And Equity Raise To Fund 4.5 GW South Carolina Solar Cell Plant; Expects Completion Late 2027

ServiceTitan Sees Q3 Sales $285.000M-$287.000M vs $287.874M Est

LiqTech International Announces David Noerby Foss Kowalczyk To Resign As CFO And COO Effective November 30, 2026

Braze Raises FY2027 Adj EPS Guidance from $0.61-$0.65 to $0.64-$0.65 vs $0.63 Est; Raises FY2027 Sales Guidance from $884.000M-$889.000M to $910.000M-$913.000M vs $898.085M Est

Protagonist Therapeutics Announces $300M Buyback Plan

Carlsmed Announces Promotion Of Jeff Bertolini To COO, Effective Immediately

Mission Produce Q3 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $450.000M Beat $367.475M Estimate

8-K filing — Everus Construction Group, Inc. (ECG)

Filed: 2026-09-08 AccNo: 0002015845-26-000056 Size: 169 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K filing — Braze, Inc. (BRZE)

Filed: 2026-09-08 AccNo: 0001676238-26-000039 Size: 705 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — Braveheart Bio, Inc. (BRVE)

Filed: 2026-09-08 AccNo: 0001628280-26-060904 Size: 367 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — Wheeler Real Estate Investment Trust, Inc. (WHLRL)

Filed: 2026-09-08 AccNo: 0001527541-26-000331 Size: 196 KB Item 3.02: Unregistered Sales of Equity Securities

8-K filing — ServiceTitan, Inc. (TTAN)

Filed: 2026-09-08 AccNo: 0001638826-26-000093 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — BJ's Wholesale Club Holdings, Inc. (BJ)

Filed: 2026-09-08 AccNo: 0001104659-26-105906 Size: 186 KB Item 8.01: Other Events

8-K filing — CARLSMED, INC. (CARL)

Filed: 2026-09-08 AccNo: 0001794546-26-000018 Size: 181 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — SANGAMO THERAPEUTICS, INC (SGMOQ)

Filed: 2026-09-08 AccNo: 0001104659-26-105905 Size: 4 MB Item 1.03: Bankruptcy or Receivership Item 2.01: Completion of Acquisition or Disposition of Assets Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — FIRST COMMUNITY CORP /SC/ (FCCO)

Filed: 2026-09-08 AccNo: 0001552781-26-000475 Size: 14 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — XCF Global, Inc. (SAFX)

Filed: 2026-09-08 AccNo: 0001493152-26-041766 Size: 318 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

8-K filing — Medalist Diversified, Inc. (MDRR)

Filed: 2026-09-08 AccNo: 0001104659-26-105902 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits

8-K filing — Cytosorbents Corp (CTSO)

Filed: 2026-09-08 AccNo: 0001104659-26-105901 Size: 205 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

8-K filing — Intellia Therapeutics, Inc. (NTLA)

Filed: 2026-09-08 AccNo: 0001193125-26-385194 Size: 257 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — FINANCIAL INSTITUTIONS INC (FIISP)

Filed: 2026-09-08 AccNo: 0001193125-26-385193 Size: 152 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

8-K filing — ARCBEST CORP /TX/ (ARCB)

Filed: 2026-09-08 AccNo: 0001104659-26-105900 Size: 221 KB Item 7.01: Regulation FD Disclosure

Northern Technologies International Elects Gautam Ramdas President, CEO, Effective Sept. 4, Succeeding G. Patrick Lnych, Who Will Become Chairman; Brian Haglund Promoted To Operations Chief

Keros Therapeutics Reveals $5M Share Repurchase Authorization

Pyxis Oncology To Present Updated Phase 1 MICVO Data In Head And Neck Cancer On A Live Webcast On September 9, 2026 At 7:30 a.m. ET

Assembly Biosciences Announces Exercise Of Option To Share 40% Of U.S. Development Costs And Profits For Gilead-Partnered HSV Helicase-Primase Inhibitor Program In Recurrent Genital Herpes

Iran's IRGC Navy Warns All Crew Of Oil Tankers In Vicinity Of Kuwaiti And Bahraini Ports That Host Americans To Evacuate

AdaptHealth Corp. Appoints Harriss T. Currie CFO, Effective Sept. 9, Succeeding Jason Clemens

If You Invested $1000 In Arch Capital Group Stock 15 Years Ago, You Would Have This Much Today

Arch Capital Group (NASDAQ:ACGL) has outperformed the market over the past 15 years by 2.29% on an annualized basis producing an average annual return of 15.49%. Currently, Arch Capital Group has a market capitalization